370 related articles for article (PubMed ID: 30999681)
1. Advances in the Understanding of Skin Cancer: Ultraviolet Radiation, Mutations, and Antisense Oligonucleotides as Anticancer Drugs.
Laikova KV; Oberemok VV; Krasnodubets AM; Gal'chinsky NV; Useinov RZ; Novikov IA; Temirova ZZ; Gorlov MV; Shved NA; Kumeiko VV; Makalish TP; Bessalova EY; Fomochkina II; Esin AS; Volkov ME; Kubyshkin AV
Molecules; 2019 Apr; 24(8):. PubMed ID: 30999681
[TBL] [Abstract][Full Text] [Related]
2. UV-Induced Molecular Signaling Differences in Melanoma and Non-melanoma Skin Cancer.
Liu-Smith F; Jia J; Zheng Y
Adv Exp Med Biol; 2017; 996():27-40. PubMed ID: 29124688
[TBL] [Abstract][Full Text] [Related]
3. Activity of a novel bcl-2/bcl-xL-bispecific antisense oligonucleotide against tumors of diverse histologic origins.
Gautschi O; Tschopp S; Olie RA; Leech SH; Simões-Wüst AP; Ziegler A; Baumann B; Odermatt B; Hall J; Stahel RA; Zangemeister-Wittke U
J Natl Cancer Inst; 2001 Mar; 93(6):463-71. PubMed ID: 11259472
[TBL] [Abstract][Full Text] [Related]
4. Ultraviolet damage, DNA repair and vitamin D in nonmelanoma skin cancer and in malignant melanoma: an update.
Reichrath J; Rass K
Adv Exp Med Biol; 2014; 810():208-33. PubMed ID: 25207368
[TBL] [Abstract][Full Text] [Related]
5. Mcl-1 antisense therapy chemosensitizes human melanoma in a SCID mouse xenotransplantation model.
Thallinger C; Wolschek MF; Wacheck V; Maierhofer H; Günsberg P; Polterauer P; Pehamberger H; Monia BP; Selzer E; Wolff K; Jansen B
J Invest Dermatol; 2003 Jun; 120(6):1081-6. PubMed ID: 12787138
[TBL] [Abstract][Full Text] [Related]
6. Ultraviolet Radiations: Skin Defense-Damage Mechanism.
Mohania D; Chandel S; Kumar P; Verma V; Digvijay K; Tripathi D; Choudhury K; Mitten SK; Shah D
Adv Exp Med Biol; 2017; 996():71-87. PubMed ID: 29124692
[TBL] [Abstract][Full Text] [Related]
7. The systemic treatment of advanced cutaneous melanoma.
Logan TF
Facial Plast Surg Clin North Am; 2003 Feb; 11(1):75-85. PubMed ID: 15062290
[No Abstract] [Full Text] [Related]
8. Bcl-X(L) is a chemoresistance factor in human melanoma cells that can be inhibited by antisense therapy.
Heere-Ress E; Thallinger C; Lucas T; Schlagbauer-Wadl H; Wacheck V; Monia BP; Wolff K; Pehamberger H; Jansen B
Int J Cancer; 2002 May; 99(1):29-34. PubMed ID: 11948488
[TBL] [Abstract][Full Text] [Related]
9. [Apoptosis, UV-radiation, precancerosis and skin tumors].
Tomas D
Acta Med Croatica; 2009 Oct; 63 Suppl 2():53-8. PubMed ID: 19999548
[TBL] [Abstract][Full Text] [Related]
10. Antitumor effect of c-myc antisense phosphorothioate oligodeoxynucleotides on human melanoma cells in vitro and and in mice.
Leonetti C; D'Agnano I; Lozupone F; Valentini A; Geiser T; Zon G; Calabretta B; Citro G C; Zupi G
J Natl Cancer Inst; 1996 Apr; 88(7):419-29. PubMed ID: 8618233
[TBL] [Abstract][Full Text] [Related]
11. UV-induced skin cancer: similarities--variations.
Boukamp P
J Dtsch Dermatol Ges; 2005 Jul; 3(7):493-503. PubMed ID: 15967008
[TBL] [Abstract][Full Text] [Related]
12. Ursolic acid differentially modulates apoptosis in skin melanoma and retinal pigment epithelial cells exposed to UV-VIS broadband radiation.
Lee YH; Wang E; Kumar N; Glickman RD
Apoptosis; 2014 May; 19(5):816-28. PubMed ID: 24375173
[TBL] [Abstract][Full Text] [Related]
13. Bcl-2 antisense oligonucleotides (G3139) inhibit Merkel cell carcinoma growth in SCID mice.
Schlagbauer-Wadl H; Klosner G; Heere-Ress E; Waltering S; Moll I; Wolff K; Pehamberger H; Jansen B
J Invest Dermatol; 2000 Apr; 114(4):725-30. PubMed ID: 10733680
[TBL] [Abstract][Full Text] [Related]
14. UV damage and DNA repair in malignant melanoma and nonmelanoma skin cancer.
Rass K; Reichrath J
Adv Exp Med Biol; 2008; 624():162-78. PubMed ID: 18348455
[TBL] [Abstract][Full Text] [Related]
15. [Ultraviolet A-induced DNA damage: role in skin cancer].
Beani JC
Bull Acad Natl Med; 2014 Feb; 198(2):273-95. PubMed ID: 26263704
[TBL] [Abstract][Full Text] [Related]
16. Basal cell carcinoma, squamous cell carcinoma and melanoma of the head and face.
Feller L; Khammissa RAG; Kramer B; Altini M; Lemmer J
Head Face Med; 2016 Feb; 12():11. PubMed ID: 26850723
[TBL] [Abstract][Full Text] [Related]
17. P53 protein and pathogenesis of melanoma and nonmelanoma skin cancer.
Benjamin CL; Melnikova VO; Ananthaswamy HN
Adv Exp Med Biol; 2008; 624():265-82. PubMed ID: 18348463
[TBL] [Abstract][Full Text] [Related]
18. Oblimersen: Augmerosen, BCL-2 antisense oligonucleotide - Genta, G 3139, GC 3139, oblimersen sodium.
Drugs R D; 2007; 8(5):321-34. PubMed ID: 17767397
[TBL] [Abstract][Full Text] [Related]
19. Oxidative stress in malignant melanoma and non-melanoma skin cancer.
Sander CS; Hamm F; Elsner P; Thiele JJ
Br J Dermatol; 2003 May; 148(5):913-22. PubMed ID: 12786821
[TBL] [Abstract][Full Text] [Related]
20. Fate of UVB-induced p53 mutations in SKH-hr1 mouse skin after discontinuation of irradiation: relationship to skin cancer development.
Melnikova VO; Pacifico A; Chimenti S; Peris K; Ananthaswamy HN
Oncogene; 2005 Oct; 24(47):7055-63. PubMed ID: 16007135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
